-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Sa0/bFWI15IrE3xQ0hfeqf8X2G4KLidnFiVon2aRpIPWR5OA0qo3GpIpPQeXJqeo
 uu9Vvn245wXLl4fJrnUAYg==

<SEC-DOCUMENT>0001451516-09-000001.txt : 20090407
<SEC-HEADER>0001451516-09-000001.hdr.sgml : 20090407
<ACCEPTANCE-DATETIME>20090407143106
ACCESSION NUMBER:		0001451516-09-000001
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20090407
DATE AS OF CHANGE:		20090407
EFFECTIVENESS DATE:		20090407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Across America Financial Services, Inc.
		CENTRAL INDEX KEY:			0001389870
		STANDARD INDUSTRIAL CLASSIFICATION:	LOAN BROKERS [6163]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-130002
		FILM NUMBER:		09737304

	BUSINESS ADDRESS:	
		STREET 1:		700 SEVENTEENTH STREET
		STREET 2:		SUITE 1200
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		303-893-1003

	MAIL ADDRESS:	
		STREET 1:		700 SEVENTEENTH STREET
		STREET 2:		SUITE 1200
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0301</schemaVersion>

    <submissionType>D</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001389870</cik>
        <entityName>Across America Financial Services, Inc.</entityName>
        <issuerAddress>
            <street1>5350 S. Roslyn St.</street1>
            <street2>Suite 400</street2>
            <city>Greenwood Village</city>
            <stateOrCountry>CO</stateOrCountry>
            <zipCode>80111</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>303-867-3416</issuerPhoneNumber>
        <issuerPreviousNameList>
            <value>None</value>
        </issuerPreviousNameList>
        <jurisdictionOfInc>CO</jurisdictionOfInc>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <withinFiveYears>true</withinFiveYears>
            <value>2005</value>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Vicki</firstName>
                <middleName></middleName>
                <lastName>Barone</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>5350 S. Roslyn St.</street1>
                <street2>Suite 400</street2>
                <city>Greenwood Village</city>
                <stateOrCountry>CO</stateOrCountry>
                <zipCode>80111</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>Nominated to become a director</relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Biotechnology</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>No Revenues</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>false</isAmendment>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-03-31</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
            <isOptionToAcquireType>true</isOptionToAcquireType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>true</isBusinessCombinationTransaction>
            <clarificationOfResponse>The issuer's securities are being issued in connection with a merger transaction.</clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList>
            <recipient>
                <recipientName>Bathgate Capital Partners LLC</recipientName>
                <recipientCRDNumber>38923</recipientCRDNumber>
                <associatedBDName>None</associatedBDName>
                <associatedBDCRDNumber>None</associatedBDCRDNumber>
                <recipientAddress>
                    <street1>5350 S. Roslyn St.</street1>
                    <street2>Suite 400</street2>
                    <city>Greenwood Village</city>
                    <stateOrCountry>CO</stateOrCountry>
                    <zipCode>80111</zipCode>
                </recipientAddress>
                <statesOfSolicitationList>
                    <state>CO</state>
                </statesOfSolicitationList>
            </recipient>
        </salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>20292075</totalOfferingAmount>
            <totalAmountSold>20292075</totalAmountSold>
            <totalRemaining>0</totalRemaining>
            <clarificationOfResponse>Shares of stock of the Company were exchanged 1 for 1 for the outstanding shares of Apro Bio Pharmaceutical Corporation.  The shares are valued at $1 for purposes of this notice.</clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>true</hasNonAccreditedInvestors>
            <numberNonAccreditedInvestors>12</numberNonAccreditedInvestors>
            <totalNumberAlreadyInvested>143</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse>Bathgate Capital Partners LLC received a merger advisory fee of 1,750,000 warrants to purchase common stock of the Company at an exercise price of $0.001 per share.</clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse></clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>Across America Financial Services, Inc.</issuerName>
                <signatureName>/s/ Vicki Barone</signatureName>
                <nameOfSigner>Vicki Barone</nameOfSigner>
                <signatureTitle>Chiarperson</signatureTitle>
                <signatureDate>2009-04-07</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----